We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.85%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$260B
AUM Growth
+$17.6B
Cap. Flow
+$9.95B
Cap. Flow %
3.83%
Top 10 Hldgs %
14.4%
Holding
8,581
New
810
Increased
3,919
Reduced
2,793
Closed
626

Sector Composition

Rank Sector Weight
1 Technology 9.74%
2 Financials 7.41%
3 Healthcare 6.49%
4 Consumer Discretionary 5.87%
5 Industrials 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IFMK
7726
DELISTED
iFresh Inc. Common Stock
IFMK
$1K ﹤0.01%
516
-2,250
-81% -$2.43K
CLDR
7727
CALL
DELISTED
Cloudera, Inc.
CLDR
$1K ﹤0.01%
+100
New +$923
ONTXW
7728
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
$1K ﹤0.01%
3,784
NSPRW
7729
DELISTED
InspireMD, Inc. Warrants
NSPRW
$1K ﹤0.01%
59,160
+300
+0.5% +$2
BRPAR
7730
DELISTED
Big Rock Partners Acquisition Corp. Right
BRPAR
$1K ﹤0.01%
5,709
MFAC.WS
7731
DELISTED
Megalith Financial Acquisition Corp. Warrants, each warrant exercisable for one share of Class A Com
MFAC.WS
$1K ﹤0.01%
2,000
+1,600
+400% +$485
HCCHR
7732
DELISTED
HL Acquisitions Corp. Right
HCCHR
$1K ﹤0.01%
5,700
HCCHW
7733
DELISTED
HL Acquisitions Corp. Warrant
HCCHW
$1K ﹤0.01%
4,600
+2,200
+92% +$596
KBLMR
7734
DELISTED
KBL Merger Corp. IV Rights expiring 11/9/2020
KBLMR
$1K ﹤0.01%
3,612
-100
-3% -$24
LMFAW
7735
DELISTED
LM Funding America, Inc. Warrant
LMFAW
$1K ﹤0.01%
26,849
USDY
7736
DELISTED
Pacific Global US Equity Income ETF
USDY
$1K ﹤0.01%
+25
New +$653
GSB
7737
DELISTED
GlobalSCAPE, Inc.
GSB
$1K ﹤0.01%
82
-3,151
-97% -$26.8K
BIOX.WS
7738
DELISTED
Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares
BIOX.WS
$1K ﹤0.01%
2,328
BVAL
7739
DELISTED
Brand Value ETF
BVAL
$1K ﹤0.01%
+71
New +$1.15K
NEBUW
7740
DELISTED
Nebula Acquisition Corporation Warrant
NEBUW
$1K ﹤0.01%
+1,200
New +$1.03K
NUROW
7741
DELISTED
NeuroMetrix, Inc. Warrants
NUROW
$1K ﹤0.01%
1,997
BVXVW
7742
DELISTED
BiondVax Pharmaceuticals Ltd.
BVXVW
$1K ﹤0.01%
1,203
PBBI
7743
DELISTED
PB Bancorp, Inc. Common Stock
PBBI
$1K ﹤0.01%
119
-812
-87% -$9.13K
DLBR
7744
DELISTED
VelocityShares Short LIBOR ETN
DLBR
$1K ﹤0.01%
+38
New +$858
CTACU
7745
DELISTED
ChaSerg Technology Acquisition Corp. Unit
CTACU
$1K ﹤0.01%
100
AVEO
7746
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$1K ﹤0.01%
224
+24
+12% +$206
TKKSW
7747
DELISTED
TKK Symphony Acquisition Corporation Warrant
TKKSW
$1K ﹤0.01%
4,800
MNI
7748
DELISTED
The McClatchy Company Class A Common Stock
MNI
$1K ﹤0.01%
461
-4,297
-90% -$12.8K
IDXG
7749
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$1K ﹤0.01%
100
-618
-86% -$4.52K
JASN
7750
DELISTED
Jason Industries, Inc.
JASN
$1K ﹤0.01%
+1,916
New +$2.27K

Similar funds

UBS Group's Q2 2019 Portfolio in Review

As of Q2 2019, UBS Group held 8,581 positions worth $260B, up 7.3% from $242B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group deployed $9.95B of net new capital in Q2 2019, opening 810 new positions and adding to 3,919 existing holdings. Its largest new stake was Dow Inc: 4,472,376 shares worth $221M.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $377M trimmed.

  • UBS Group's largest Q2 2019 buy was Dow Inc: 4,472,376 shares worth $221M.
  • UBS Group added most to UBS Group in Q2 2019, an estimated $1.59B increase.
  • UBS Group's biggest Q2 2019 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $377M.
  • UBS Group fully exited Bemis in Q2 2019, selling an estimated $102M.
  • UBS Group's ten largest holdings make up 14% of its $260B portfolio in Q2 2019.
  • UBS Group opened 810 new positions and closed 626 in Q2 2019.
  • UBS Group's portfolio value rose 7.3% quarter-over-quarter to $260B.

Based on UBS Group's 13F filing for Q2 2019, filed 14 Aug 2019.